Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

HDAC7 regulates histone 3 lysine 27 acetylation and transcriptional activity at super-enhancer-associated genes in breast cancer stem cells.

Caslini C, Hong S, Ban YJ, Chen XS, Ince TA.

Oncogene. 2019 Aug 2. doi: 10.1038/s41388-019-0897-0. [Epub ahead of print]

PMID:
31375747
2.

Analysis of 19 Minerals and Cortisol in Red Deer Hair in Two Different Areas of the Stelvio National Park: A Preliminary Study.

Montillo M, Caslini C, Peric T, Prandi A, Netto P, Tubaro F, Pedrotti L, Bianchi A, Mattiello S.

Animals (Basel). 2019 Jul 26;9(8). pii: E492. doi: 10.3390/ani9080492.

3.

High-resolution array-CGH analysis on 46,XX patients affected by early onset primary ovarian insufficiency discloses new genes involved in ovarian function.

Bestetti I, Castronovo C, Sironi A, Caslini C, Sala C, Rossetti R, Crippa M, Ferrari I, Pistocchi A, Toniolo D, Persani L, Marozzi A, Finelli P.

Hum Reprod. 2019 Mar 1;34(3):574-583. doi: 10.1093/humrep/dey389.

4.

GATA6 phosphorylation by Erk1/2 propels exit from pluripotency and commitment to primitive endoderm.

Meng Y, Moore R, Tao W, Smith ER, Tse JD, Caslini C, Xu XX.

Dev Biol. 2018 Apr 1;436(1):55-65. doi: 10.1016/j.ydbio.2018.02.007. Epub 2018 Feb 15.

5.

Identification of a cancer stem cell-specific function for the histone deacetylases, HDAC1 and HDAC7, in breast and ovarian cancer.

Witt AE, Lee CW, Lee TI, Azzam DJ, Wang B, Caslini C, Petrocca F, Grosso J, Jones M, Cohick EB, Gropper AB, Wahlestedt C, Richardson AL, Shiekhattar R, Young RA, Ince TA.

Oncogene. 2017 Mar 23;36(12):1707-1720. doi: 10.1038/onc.2016.337. Epub 2016 Oct 3.

6.

Low-Dose Paclitaxel Reduces S100A4 Nuclear Import to Inhibit Invasion and Hematogenous Metastasis of Cholangiocarcinoma.

Cadamuro M, Spagnuolo G, Sambado L, Indraccolo S, Nardo G, Rosato A, Brivio S, Caslini C, Stecca T, Massani M, Bassi N, Novelli E, Spirli C, Fabris L, Strazzabosco M.

Cancer Res. 2016 Aug 15;76(16):4775-84. doi: 10.1158/0008-5472.CAN-16-0188. Epub 2016 Jun 21.

7.
8.

Loss of GATA4 and GATA6 expression specifies ovarian cancer histological subtypes and precedes neoplastic transformation of ovarian surface epithelia.

Cai KQ, Caslini C, Capo-chichi CD, Slater C, Smith ER, Wu H, Klein-Szanto AJ, Godwin AK, Xu XX.

PLoS One. 2009 Jul 31;4(7):e6454. doi: 10.1371/journal.pone.0006454.

9.

MLL associates with telomeres and regulates telomeric repeat-containing RNA transcription.

Caslini C, Connelly JA, Serna A, Broccoli D, Hess JL.

Mol Cell Biol. 2009 Aug;29(16):4519-26. doi: 10.1128/MCB.00195-09. Epub 2009 Jun 15.

10.

Interaction of MLL amino terminal sequences with menin is required for transformation.

Caslini C, Yang Z, El-Osta M, Milne TA, Slany RK, Hess JL.

Cancer Res. 2007 Aug 1;67(15):7275-83.

11.

Abomasal nematode community in an alpine chamois (Rupicapra r. rupicapra) population before and after a die-off.

Citterio CV, Caslini C, Milani F, Sala M, Ferrari N, Lanfranchi P.

J Parasitol. 2006 Oct;92(5):918-27.

12.

Histone modifications silence the GATA transcription factor genes in ovarian cancer.

Caslini C, Capo-chichi CD, Roland IH, Nicolas E, Yeung AT, Xu XX.

Oncogene. 2006 Aug 31;25(39):5446-61. Epub 2006 Apr 10.

PMID:
16607277
13.

p53 differentially inhibits cell growth depending on the mechanism of telomere maintenance.

Razak ZR, Varkonyi RJ, Kulp-McEliece M, Caslini C, Testa JR, Murphy ME, Broccoli D.

Mol Cell Biol. 2004 Jul;24(13):5967-77.

14.

Modulation of cell cycle by graded expression of MLL-AF4 fusion oncoprotein.

Caslini C, Serna A, Rossi V, Introna M, Biondi A.

Leukemia. 2004 Jun;18(6):1064-71.

PMID:
14990976
15.

The amino terminus targets the mixed lineage leukemia (MLL) protein to the nucleolus, nuclear matrix and mitotic chromosomal scaffolds.

Caslini C, Alarcòn AS, Hess JL, Tanaka R, Murti KG, Biondi A.

Leukemia. 2000 Nov;14(11):1898-908.

PMID:
11069025
16.

The amino terminus of the mixed lineage leukemia protein (MLL) promotes cell cycle arrest and monocytic differentiation.

Caslini C, Shilatifard A, Yang L, Hess JL.

Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2797-802.

17.

Identification of a novel molecular partner of the E2A gene in childhood leukemia.

Brambillasca F, Mosna G, Colombo M, Rivolta A, Caslini C, Minuzzo M, Giudici G, Mizzi L, Biondi A, Privitera E.

Leukemia. 1999 Mar;13(3):369-75.

PMID:
10086727
18.

Identification of two novel isoforms of the ZNF162 gene: a growing family of signal transduction and activator of RNA proteins.

Caslini C, Spinelli O, Cazzaniga G, Golay J, De Gioia L, Pedretti A, Breviario F, Amaru R, Barbui T, Biondi A, Introna M, Rambaldi A.

Genomics. 1997 Jun 1;42(2):268-77.

PMID:
9192847
19.

Detection of ALL-1/AF4 fusion transcript by reverse transcription-polymerase chain reaction for diagnosis and monitoring of acute leukemias with the t(4;11) translocation.

Biondi A, Rambaldi A, Rossi V, Elia L, Caslini C, Basso G, Battista R, Barbui T, Mandelli F, Masera G, et al.

Blood. 1993 Nov 15;82(10):2943-7.

20.

Clinical and biological effects of erythropoietin treatment of myelodysplastic syndrome.

Razzano M, Caslini C, Cortelazzo S, Battistel V, Rambaldi A, Barbui T.

Leuk Lymphoma. 1993 May;10(1-2):127-34.

PMID:
8374520
21.

Therapy with human recombinant erythropoietin in patients with myelodysplastic syndromes.

Razzano M, Caslini C, Cortelazzo S, Battistel V, Rambaldi A, Barbui T.

Br J Haematol. 1992 Aug;81(4):628-30. No abstract available.

PMID:
1390262
22.

Organ-specific growth of a murine lymphoma of spontaneous origin in nude mice.

Tomasoni A, Scanziani E, Massazza G, Giudici G, Sironi G, Caslini C, Rambaldi A, Giavazzi R.

Clin Exp Metastasis. 1991 Sep-Oct;9(5):485-97.

PMID:
1914281

Supplemental Content

Loading ...
Support Center